NR 508 ADVANCED PHARMACOLOGY COMPREHENSIVE FINAL EXAM
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
INSTRUCTIONS
Select the single best answer for each question.
Each question has one correct answer and three plausible distractors.
This final exam is comprehensive covering cardiovascular drugs, psychopharmacology, endocrine
medications, pain management, antimicrobial therapy, and special population considerations .
Questions focus on clinical decision-making, drug selection, monitoring parameters, and patient education .
Assume standard graduate-level knowledge.
SECTION I: CARDIOVASCULAR PHARMACOLOGY (Questions 1-15)
Q1. Ray has been diagnosed with hypertension and an ACE inhibitor is determined to be needed. Prior to
prescribing this drug, the NP should assess for:
A) Hypokalemia
B) Impotence
C) Decreased renal function
D) Inability to concentrate
Answer: C
Rationale: Prior to prescribing an ACE inhibitor, renal function should be assessed because these drugs affect
renal hemodynamics and can cause hyperkalemia and renal impairment in susceptible patients . ACE
inhibitors do not typically cause hypokalemia (A); they cause hyperkalemia. Impotence (B) is not a primary
concern before initiating therapy .
, NR 508 ADVANCED PHARMACOLOGY COMPREHENSIVE FINAL EXAM
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
Bloom Level: Comprehension
Q2. Angiotensin-converting enzyme inhibitors are the drug of choice in treating hypertension in diabetic
patients because they:
A) Improve insulin sensitivity
B) Improve renal hemodynamics
C) Reduce the production of angiotensin II
D) All of the above
Answer: D
Rationale: ACE inhibitors are preferred in diabetic patients for multiple reasons: they improve insulin
sensitivity, improve renal hemodynamics (reducing proteinuria and slowing diabetic nephropathy
progression), and reduce angiotensin II production. All of these contribute to their benefit in diabetic
hypertensive patients .
Bloom Level: Comprehension
Q3. A potentially life-threatening adverse response to ACE inhibitors is angioedema. Which of the following
statements is true about this adverse response?
A) Swelling of the tongue or hoarseness are the most common symptoms
B) It appears to be related to the decrease in aldosterone production
C) Presence of a dry, hacky cough indicates a high risk for this adverse response
D) Because it takes time to build up a blood level, it occurs after being on the drug for about 1 week
, NR 508 ADVANCED PHARMACOLOGY COMPREHENSIVE FINAL EXAM
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
Answer: A
Rationale: Angioedema from ACE inhibitors can present with swelling of the tongue, lips, or face, and
hoarseness or stridor indicates airway involvement—a medical emergency . The cough (C) is a separate
common side effect but does not predict angioedema. The onset can occur at any time during therapy, not just
after 1 week (D) .
Bloom Level: Comprehension
Q4. Despite good blood pressure control, an NP might change a patient's drug from an ACE inhibitor to an
ARB because the ARB:
A) Is stronger than the ACE inhibitor
B) Does not produce a dry, hacky cough
C) Has no effect on the renal system
D) Reduces sodium and water retention
Answer: B
Rationale: ARBs are often substituted for ACE inhibitors when patients develop the bothersome dry cough
associated with ACE inhibitors . ARBs have comparable efficacy to ACE inhibitors (A) and similar renal
effects (C) .
Bloom Level: Comprehension
Q5. Laboratory monitoring for patients on ACE inhibitors or ARBs should include:
A) White blood cell counts with the drug dosage increased for elevations above 10,000
B) Liver function tests with the drug dosage stopped for ALT values twice that of normal
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
INSTRUCTIONS
Select the single best answer for each question.
Each question has one correct answer and three plausible distractors.
This final exam is comprehensive covering cardiovascular drugs, psychopharmacology, endocrine
medications, pain management, antimicrobial therapy, and special population considerations .
Questions focus on clinical decision-making, drug selection, monitoring parameters, and patient education .
Assume standard graduate-level knowledge.
SECTION I: CARDIOVASCULAR PHARMACOLOGY (Questions 1-15)
Q1. Ray has been diagnosed with hypertension and an ACE inhibitor is determined to be needed. Prior to
prescribing this drug, the NP should assess for:
A) Hypokalemia
B) Impotence
C) Decreased renal function
D) Inability to concentrate
Answer: C
Rationale: Prior to prescribing an ACE inhibitor, renal function should be assessed because these drugs affect
renal hemodynamics and can cause hyperkalemia and renal impairment in susceptible patients . ACE
inhibitors do not typically cause hypokalemia (A); they cause hyperkalemia. Impotence (B) is not a primary
concern before initiating therapy .
, NR 508 ADVANCED PHARMACOLOGY COMPREHENSIVE FINAL EXAM
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
Bloom Level: Comprehension
Q2. Angiotensin-converting enzyme inhibitors are the drug of choice in treating hypertension in diabetic
patients because they:
A) Improve insulin sensitivity
B) Improve renal hemodynamics
C) Reduce the production of angiotensin II
D) All of the above
Answer: D
Rationale: ACE inhibitors are preferred in diabetic patients for multiple reasons: they improve insulin
sensitivity, improve renal hemodynamics (reducing proteinuria and slowing diabetic nephropathy
progression), and reduce angiotensin II production. All of these contribute to their benefit in diabetic
hypertensive patients .
Bloom Level: Comprehension
Q3. A potentially life-threatening adverse response to ACE inhibitors is angioedema. Which of the following
statements is true about this adverse response?
A) Swelling of the tongue or hoarseness are the most common symptoms
B) It appears to be related to the decrease in aldosterone production
C) Presence of a dry, hacky cough indicates a high risk for this adverse response
D) Because it takes time to build up a blood level, it occurs after being on the drug for about 1 week
, NR 508 ADVANCED PHARMACOLOGY COMPREHENSIVE FINAL EXAM
2026/2027 | MOST TESTED | 50 VERIFIED Q&A | MULTIPLE-CHOICE |
DETAILED RATIONALES | PASS GUARANTEED - A+ GRADED
Answer: A
Rationale: Angioedema from ACE inhibitors can present with swelling of the tongue, lips, or face, and
hoarseness or stridor indicates airway involvement—a medical emergency . The cough (C) is a separate
common side effect but does not predict angioedema. The onset can occur at any time during therapy, not just
after 1 week (D) .
Bloom Level: Comprehension
Q4. Despite good blood pressure control, an NP might change a patient's drug from an ACE inhibitor to an
ARB because the ARB:
A) Is stronger than the ACE inhibitor
B) Does not produce a dry, hacky cough
C) Has no effect on the renal system
D) Reduces sodium and water retention
Answer: B
Rationale: ARBs are often substituted for ACE inhibitors when patients develop the bothersome dry cough
associated with ACE inhibitors . ARBs have comparable efficacy to ACE inhibitors (A) and similar renal
effects (C) .
Bloom Level: Comprehension
Q5. Laboratory monitoring for patients on ACE inhibitors or ARBs should include:
A) White blood cell counts with the drug dosage increased for elevations above 10,000
B) Liver function tests with the drug dosage stopped for ALT values twice that of normal
